Work

The burden of yersiniosis in New Zealand, 2022

Year: 2025

Type: article

Abstract: AIM: To estimate the burden of yersiniosis and sequelae in New Zealand, expressed as disability-adjusted life years (DALYs). METHODS: Information on the incidence of yersiniosis was taken from the New Zealand notifiable disease database (EpiSurv). Information on the duration and subsequent sequelae (reactive arthritis, erythema nodosum) were obtained from a New Zealand case-control study. Transition factors (e.g., proportion of cases for which a specimen is requested, proportion of cases providing a specimen) were taken from the New Zealand Acute Gastrointestinal Illness (AGI) Study. Disability weights used to calculate DALYs were those from the 2013 Global Burden of Disease Study. RESULTS: For 2022, the burden of yersiniosis in New Zealand was estimated to be 119 (95% credible interval 41.5-243) DALYs. Most of the burden (110/119 DALYs) was due to primary gastroenteritis. Rates of reactive arthritis and erythema nodosum were similar to those observed in overseas studies. CONCLUSION: The burden of disease due to yersiniosis is predominantly due to the long duration of the gastrointestinal disease, with relatively minor contributions from sequelae.

Source: New Zealand Medical Journal

DOI: 10.26635/6965.6730

Authors: Peter Cressey, Beverley Horn, Brent Gilpin, Lucia Rivas

Institution: New Zealand Institute for Public Health and Forensic Science

Language: English

Topic: Yersinia bacterium, plague, ectoparasites research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4408815816